Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).
about
The Rationale for Insulin Therapy in Alzheimer's DiseaseCognitive dysfunction and diabetes mellitusNeurocognitive changes and their neural correlates in patients with type 2 diabetes mellitusIs type 2 diabetes related to leukoaraiosis? an updated review.White matter hyperintensities and geriatric syndrome: An important role of arterial stiffness.Diabetes mellitus and white matter hyperintensity.Beclin-1- mediated autophagy may be involved in the elderly cognitive and affective disorders in streptozotocin-induced diabetic miceBiomarkers of cerebrovascular disease in dementia.Classification of white matter lesions on magnetic resonance imaging in elderly personsCranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample.Human cerebral neuropathology of Type 2 diabetes mellitusType 2 diabetes mellitus, cognition and brain in aging: A brief reviewTesting covariates of Type 2 diabetes-cognition associations in older adults: moderating or mediating effects?Brain structural changes and their correlation with vascular disease in type 2 diabetes mellitus patients: a voxel-based morphometric studyThe cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.Physical performance is associated with executive functioning in older african american women.Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose.Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications.C-reactive protein is linked to lower cognitive performance in overweight and obese womenFactors associated with cognitive decline in elderly diabetics.Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitusImpact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment.Diabetes, sugar-coated but harmful to the brain.G-CSF and cognitive dysfunction in elderly diabetic mice with cerebral small vessel disease: Preventive intervention effects and underlying mechanisms.Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.Memory dysfunction in type 2 diabetes mellitus correlates with reduced hippocampal CA1 and subiculum volumes.Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia.Relation between dairy food intake and cognitive function: The Maine-Syracuse Longitudinal StudyObesity and insulin resistance are associated with reduced activity in core memory regions of the brain.Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes.Cognitive dysfunction: an emerging concept of a new diabetic complication in the elderly.Views and opinion on BDNF as a target for diabetic cognitive dysfunction.Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications.Blood-Brain Barrier Disruption, Vascular Impairment, and Ischemia/Reperfusion Damage in Diabetic Stroke.Risk factors for a 6-year decline in physical disability and functional limitations among elderly people with type 2 diabetes in the Japanese Elderly Diabetes Intervention Trial.Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy.Thalamic resting-state functional connectivity: disruption in patients with type 2 diabetes.Clinical and Sociodemographic Factors Associated with Cognitive Impairment and Neuroprotection in Diabetes Patients.
P2860
Q26744834-A09B4CD7-BFE8-448B-AAB0-CF2BF9B3E321Q30489305-24304CE1-58AE-434E-820B-A613C13332FFQ30836865-CA98F9AC-7F07-46EB-8AF9-5518A06F6614Q30910261-056D645C-8452-475B-9182-AC1B9565D6AEQ31032253-EBBB9E63-628D-43C7-A26A-9EF6D50EFA21Q31032256-0DD2A254-4A92-4693-BDC9-4C023CECB8CFQ31150352-4456ABE3-E744-4E8C-B24C-E200E788DB04Q31153979-FD3E0162-F820-409F-B089-8ED190B50FEEQ31155156-3C9E5438-E854-4665-BED4-830CC8BBFE23Q33603254-FDA93B08-8A7A-4777-BB5A-4E38B3CB15FEQ33710643-5C88D249-8AF4-4C13-87E8-81417FE7062FQ33849810-61B44607-7C15-4243-BD47-9C9A9FCC6654Q34102777-436F349C-B64E-4E51-95C7-A8057AE8CD57Q34319623-ED243004-8209-48FE-80C0-1A3167438D5FQ34545383-CC6E2409-E56A-4077-8F6D-8454E91B7A2BQ34725346-99DE1486-D4DB-4D0B-8EDB-6D251F20E86EQ34762299-D84E2D1D-9815-4A90-B001-FC3A69F41A3EQ35032598-8400D4E1-4130-4A6F-956A-5E64ECE1A007Q35050058-63247C60-EE8F-4BEA-804D-7D28D3CF69E6Q35428400-DE128852-EBD5-4498-83E9-F1B99C28E8BEQ35758653-83F0FDE6-29BD-4BC8-A14E-16E7E2C6800AQ35840859-947F7DB7-5DB9-4DA7-AFA0-256C38ED556AQ35881032-98B4BC2D-371F-4F56-BA5F-B989CD7745B6Q36295236-32090818-FEE6-4F8A-830E-38C838A0AE4AQ36318129-F1A16089-F470-4FBD-9D13-4D7C1824E477Q36333483-08BD111E-46E5-4C41-AC18-D8854C9085A5Q36650968-23CDA564-A6B7-499B-8591-ADEF1E027A52Q36811646-AB198D62-97A4-4777-9DE5-4ECF64A06C2CQ36826582-EC134CDA-39A1-4251-BFC3-E3A2287ECDA3Q37492620-EE9AB0EA-AA84-4723-B530-F052D9C439D4Q37652713-08DE2688-F488-415F-9EC9-1ED920FCB55CQ37930196-9CA3AE8D-B7AD-4BAE-93BD-D5EF954713D8Q38033680-FE76EBC3-F0BB-444D-B161-A05FD32CD0BFQ38124257-9967D5D9-470D-4332-ACAA-39B03494E968Q39170234-D1AFBD5B-D540-4732-AF14-8A9559408479Q39345035-EA2C531E-EE72-4B75-A681-0AE3B8864C0AQ39624536-006104EE-9690-42AD-8FEE-9A2F71BEE275Q40458446-D135AD93-2B8E-4DF6-BB58-D1381638CB4CQ40792050-B7FDCF9F-5C47-4AE1-BB7E-E161918B205EQ41367199-FA9B9B30-5D59-4422-978C-3F5375CC683B
P2860
Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Cognitive dysfunction associat ...... s intervention trial (J-EDIT).
@en
Cognitive dysfunction associat ...... ly diabetes intervention trial
@nl
type
label
Cognitive dysfunction associat ...... s intervention trial (J-EDIT).
@en
Cognitive dysfunction associat ...... ly diabetes intervention trial
@nl
prefLabel
Cognitive dysfunction associat ...... s intervention trial (J-EDIT).
@en
Cognitive dysfunction associat ...... ly diabetes intervention trial
@nl
P2093
P2860
P356
P1476
Cognitive dysfunction associat ...... s intervention trial (J-EDIT).
@en
P2093
Akihisa Iguchi
Atsushi Araki
Hideki Ito
Hiroyuki Umegaki
Koichi Yokono
Sachiko Mizuno
Shiro Tanaka
Taichi Akisaki
Takashi Sakurai
Toshihiro Takata
P2860
P304
P356
10.1002/DMRR.632
P577
2006-09-01T00:00:00Z